Wednesday
March 26, 2003
michigandaity.com
sportsdesk@umich.edu
heOuhTgSn~ag
10
Welcome
M' bounces back from
home
Yost getting prepped
early deficit,
By Gennaro Fice
Daily Sports Writer
When Michigan starter Matt Collins
exited yesterday's game after spotting
Central Michigan
three runs in justCER H ©
two-thirds of an
inning, it looked as
though opening day at the Fish would
be long and one-sided. Three hours
later, this first-inning prophecy had
proven true ... sort of.
The ballgame, as the 15-6 final
showed, was completely uneven, but not
in the Chippewas' favor.
YESTERDAY'S GAME
Central Michigan 6, Michigan 15
MichigAn(89) central Mictiai(5-10)
Player AB R Hi Bi Player AB R H BI
Lollo cf 2 4 2 1 Krueger rf 4 2 1 1
Sokol dh 3 1 1 0OGrubb cf 4 1 2 1
Coleman ph 1 0 0 0 LaFavors 3b 2 1 0 0
Koman 3b 5 2 3 3 Griesbaum ph 1 0 1 0
Robertsl1f 4 2 2 1iGatesi1b 3 1 1 1
Cantalamessa 3 2 1 2 Geldhof dh 5 0 1 3
Scheidt 2b 1 0 0 0 Latour 2b 4 0 0 0
Burhans rf 3 0 0 0 Gryzwacz if 2 0 0 0
Schmidt ph 1 0 0 0 Sampsell c 1 0 0 0
Wright 1b 5 1 1 2 Campbell c 2 0 0 0
Kunkel c 3 2 3 3 Welker ss 1 0 0 0
Wuerfel ph 2 0 0 0Gotwalt 2 10 0
Rudden ss 2 1 1 1 Opalewski p 0 0 0 0
Collins p 0 0 0 0 Patterson p 0 0 0 0
Tognetti 0 0 0 0 Lundquist p 0 0 0 0
Total 36 1E1413 Total 33 6 6 6
LOB - CMU 8; Michigan 5; E - Michigan 1: Gold.
schmedng (4); CMU 3: LaFavors (8); K. Sampsell 2
(2); DP - Michigan 1; 289- CMU 3: Krueger (4),
Grubb (3), Geldhof (2); Michigan 4: Lollio (5), Koman
2(9), Cantalamessa (4); HR - Lollio (2) HBP -
Krueger. LaFavorsGryzwac, Welker, Schmidt. SB-
Loliio 2(3).
wins big
After surrendering a 3-0 lead in the
top half of the first inning, Michigan
showed its resiliency by scorching Cen-
tral Michigan for seven runs in the
inning's bottom half and never looked
back.
"The kids really played hard and
responded well after we started off
(down) 3-0," Michigan coach Rich
Maloney said. "These kids just never
quit - they keep at it, and I'm real
proud of them. They showed a lot of
character in how they battled."
The 10-run, 50-minute first inning
truly decided the game's outcome. Phil
Tognetti relieved Collins for Michigan
and immediately shut down the Chippe-
was. The Wolverines then came up to
bat in the bottom of the inning facing a
three-run deficit, but quickly shifted the
momentum.
Like Collins, Central Michigan
starter Jeff Opalewski was very ineffec-
tive. Unable to hit his spots, Opalewski'
gave up four walks and a hit to Michi-
gan's first five hitters. He hit the show-
ers without recording a single out.
Nick Patterson entered the game with
the bases loaded and walked senior Jor-
dan Cantalamessa on four pitches. Still
leading 3-2, Pattterson struck out sopho-
more Chris Burhans, but this success
was short-lived. Michigan senior Nate
Wright reached on an error, knotting the
game at three and keeping the bases
loaded. Michigan's next hitter, freshman
Jeff Kunkel, tattooed a Patterson fastball
over Chippewa centerfielder Tommy
Grubb for a three-run triple. Sophomore
Nick Rudden delivered a perfect suicide
squeeze to score Kunkel. Patterson
eventually struck out Michael Sokol to
end the inning, but Michigan had gained
control of the game and led 7-3.
In the next five innings, Michigan
cruised to a 14-3 lead. While the Michi-
gan offense continued to tear apart
Chippewa hurlers, Tognetti worked
beautifully in long relief.
"Phil Tognetti did a wonderful job for
0
to host the
By Bob Hunt
Daily Sports Writer
Call it the calm before the storm.
Yost Ice Arena is pretty quiet this
week in preparation for the NCAA Ice
Hockey Midwest Regional this week-
end. The rink usually used 20 hours a
day for everything from public skating
to intramural broomball is standing still.
Instead, five crewmen and 20 stu-
dents, led by Yost rink manager Craig
Wotta, are working around the clock in
preparation for the big event.
When fans pile into the building Sat-
urday, they will notice that the advertis-
ing has been taken off the boards, the
'M' logo has been painted over on cen-
ter ice, numerous banners have been put
up and NCAA merchandise has been
placed all around. What they won't
notice is that the players lounge has
been cleared, and television sets have
been added to the press box. But all of
this is being completed while Michigan
is working to try and make the Frozen
Four for the third straight year.
"The difference is at Joe Louis Arena
if they had a regional, they would do it
when the Red Wings are out of town or
something like that," Wotta said. "We're
doing it when the team is preparing for
its biggest week of the year."
Wotta and his crew started at 6 a.m.
Monday covering the 'M' logo at center
ice with two NCAA Ice Hockey logos.
The crew shaved off a half-inch of ice
- half of the one-inch surface - and
put white paint all over the block 'M.'
Then, after putting water over the paint,
stencils were put down and painted on.
After that, the crew battled against the
70-degree weather outside to create
Big Dance'
another half-inch of ice: The tempera-
ture proved to be too much, though, as
some of the Wolverines skated around
on Monday with giant orange cones
around the face-off circle.
The crew spent eight hours taking off
all the advertising boards with lexion
protection. Yesterday, the crew started to
replace the advertising with NCAA
stickers. The lexion boards take ever
longer to put on than to take off, so they
will not be put back on until the summer.
But there is one thing that the crew
does not need to clean: the Michigan
lockerroom. Unlike last year, when
Michigan hosted the West Regional, the
NCAA has not asked the Wolverines to
move into a visiting lockerroom.
"We went through a lot of aggravation
and controversy over the lockerroom sit-
uation," Michigan coach Red Berenson
said. "This year it's not an issue. If
you're going to the trouble of hosting the
whole event, it's wise to let the home
team use their own lockerroom."
This year's preparation is also easier
because there are just four teams
instead of six. On the first day of last
year's regional, Minnesota and Denver
put their equipment in the lobby
because there weren't enough locker-
rooms.
"(Having four teams) really makes it
a lot easier," Wotta said. "This year,
nobody is going to be switching locker-
rooms. This building's much more
equipped to handle four than six."
Wotta hopes all of this preparation
will lead to an outstanding environment
for a showcase of college hockey.
esenting Yost and the athletic depart-
ment of the University as clean as possi-
ble is our goal," Wotta said.
9
47W
DAVID KATZ/Daily
Michigan senior Gino Lollio gets congratulated by his teammates after launching a
solo homerun to open the third inning. Lollio also doubled and scored four runs.
Central Michigan
Michigan
Central Michigan
Opalewski
Patterson
Lundquist
Cremeans
Sutherland
Schell
Michigan
Collins
Tognetti
Feldkamp
Murray
Husain
300 000 201
721 040 10X
R H E
6 6 3
1514 1
IP H R ER BBSO
0
1
1
2.1
2.2
1
0.2
5.1
1
1
1
1
1
4
5
3
0
2
1
2
0
1
4
3
2
5
1
0
3
0
2
0
1
3
2
2
4
1
0
3
0
0
1
3
1
0
0
0
0
1
2
1
0
0
0
2
0
2
3
1
0
1
1
1
0
us," Maloney said. "We've been waiting
for somebody to step up on the mound,
and Phil gave us a huge lift."
Tognetti (1-1) earned the win by
shutting out Central Michigan in 5.1
innings of work, giving up just one hit
and two walks. The sophomore enjoyed
15 runs of support from the Michigan
offense.
"As a pitcher, I think I can speak for
our staff that (run support) is really sig-
nificant for us," Tognetti said. "It makes
our job a lot easier."
A large portion of Michigan's offen-
sive outburst today came from Kunkel.
Besides his first-inning triple, Kunkel
had two singles and scored two runs. A
backup at catcher to junior Jake Fox -
who currently leads the Wolverines in
homeruns (7), RBIs (23), and slugging
percentage (.785), but took the day off
- Kunkel made the most of his spot-
start.
"Every so often I'm going to get a
chance, and I've got to make the most
of it," Kunkel said.
With solid performances from both
Tognetti and Kunkel, Michigan's depth
pleases Maloney.
"(Depth) is what you need to have if
you're going to be a successful ball-
club," Maloney said. "Guys need to fill
in for others and make a contribution,
and we got that today."
Michigan's victory over Central
Michigan comes just three days after a
12-8 loss to the Chippewas in the Butler
Classic.
"I'm proud of these guys for fighting
back," Maloney said. "Certainly Central
played a good game the other day and
deserved to win, and for our kids to
respond back and convincingly win this
game was a real positive."
Umpires - HP: Jim Muhleck, 1B: Mike Luptowskl;, Se
Larry Bia4orucki
At -The Fish
Attendance - 354 Time - 3:10
Bowling a split; Softball can't complete sweep
14
By Megan Kolodgy
Daily Sports Writer
BOWLING GREEN - The day
started out sunny.
Michigan's softball team spent its
first few hours in Bowling Green
happily trouncing what should have
been an easy MAC team.
The Wolverines came out of their
first game of a
doubleheaderM G
grinning about BW"N1REEN i
their 4-0 victory
over a struggling
pack of Falcons.B G
This game was an
especially auspicious one for Michi-
gan pitcher Marissa Young, who
improved her record to 10-0.
At this point, it seemed as if the
decision to change the regularly
i
i
i
scheduled game into a doubleheader
was a good one for the Wolverines.
Both teams were eager to receive the
extra playing time, as several games
on both schedules had been cancelled
due to inclement weather.
Then, the clouds rolled in.
Game two started out slowly, with
Michigan sophomore Nicole Motyc-
ka steadily handling the pitching. At
the end of the second inning, Michi-
gan coach Carol Hutchins called the
team together to adjust the hitting
strategy.
Everything seemed to be going
according to plan; the Wolverines
continued to outhit Bowling Green,
and in the top of the third, senior
Melinda Moulden drove in freshman
Tiffany Haas, putting Michigan
ahead, 1-0.
With the fourth and fifth innings
came more of the same. Motycka,
who was coming off of an impressive
five-game winning streak after a
weekend at the Boilermaker Classic
in West Lafayette, managed to hold
off Bowling Green's batting order. It
appeared as if Michigan was on its
way to another win, setting the stage
for a long weekend of Big Ten com-
petition.
But that's when it began to rain.
Despite the fact that the weather
has proven to be a big burden for the
Wolverines all season, it was not a
storm that prevented or hindered
another stellar Blue performance.
After a scoreless sixth inning for
Michigan, the defense was prepared
to ensure a similar fate for the Fal-
cons. Unfortunately for the Wolver-
ines, Bowling Green had other plans.
Motycka, who kept the Falcons at
bay for five innings, began to waver,
and Bowling Green capitalized on its
opportunity. The downward spiral
began when the Falcons started to hit,
bringing a run in to tie the game.
When Bowling Green's Libby
Voshell drove in two more runs, how-
ever, the Wolverines became more
frantic in their defensive effort.
Motycka was replaced with freshman
Jennie Ritter, who managed to hold
the Falcons for the remainder of the
inning.
Michigan struggled in vain for
runs in the final inning, but was
unable to pull off the late-game
comeback as the Falcons won 3-1.
In spite of this setback, Hutchins
continues to have faith in her players
and their effort.
"I am not disappointed with my
team," she said.
NICK AZZARO/Daily
Freshman Davis Tarwater is one of four freshman Wolverines to qualify for the
NCAAs. Tarwater played a major role In Michigan's Big Ten championship.
Blue' sdozen prepare
for NAs in Austin
By Waldemar Centeno
Daily Sports Writer
Coming off of its 32nd Big Ten
Championship, the No. 4 Michigan
men's swimming and diving team (5-0
Big Ten, 8-2 overall) is geared up for its
appearance in the NCAA Champi-
onship starting tomorrow.
"I think we have a pretty good
chance to meet our goal, which is basi-
I Er2TOA-z9 ;
[Contraceptive Injection]
medroxyprogesterone acetate injectable suspension
3ir'tk car--troI you.-tkir-vk aeot-t jus-t +x- a year
DEPO-PROVERA" Contraceptive Injection
(medroxyprogesterone acetate injectable suspension, USP)
This product is intended to prevent pregnancy. It does not protect against HIV
infection (AIDS) and other sexually transmitted diseases.
What is DEPO-PROVERA Contraceptive Injection?
DEPO-PROVERA Contraceptive Injection is a form of birth control that is given as an
intramuscular injection (a shot) in the buttock or upper arm once every 3 months (13 weeks). To
continue your contraceptive protection, you must return for your next injection promptly at the
end of 3 months (13 weeks). DEPO-PROVERA contains medroxyprogesterone acetate, a
chemical similar to (but not the same as) the natural hormone progesterone, which is produced
by your ovaries during the second half of your menstrual cycle. DEPO-PROVERA acts by
preventing your egg cells from ripening. If an egg is not released from the ovaries during your
menstrual cycle, it cannot become fertilized by sperm and result in pregnancy. DEPO-PROVERA
also causes changes in the lining of your uterus that make it less likely or pregnancy to occur
How effective is DEPO-PROVERA Contraceptive Injection?
The efficacy of DEPO-PROVERA Contraceptive Inection depends on following the
recommended dosage schedule exactly (see "How often do I get my shot of DEPO-PROVERA
Contraceptive Injection?"). To make sure you are not pregnant when you first get
DEPO-PROVERA Contraceptive Injection, your first injection must be given ONLY during
the first 5 days of a normal menstrual period; ONLY within the first 5 days after childbirth if not
breast-feeding; and, if exclusively breast-feeding, ONLY at the sixth week after childbirth. It is a
long-term injectable contraceptive when administered at 3-month (I 3-week) intervals.
DEPO-PROVERA Contraceptive Injection is over 99% effective, making it one of the most reliable
methods of birth control available. This means that the average annual pregnancy rate is less than
one for every 100 women who use DEPO-PROVERA. The effectiveness of most contraceptive
methods depends in part on how reliably each woman uses the method. The effectiveness of
DEPO-PROVERA depends only on the patient returning every 3 months (13 weeks) for her next
injection. Your health-care provider will help you compare DEPO-PROVERA with other
contraceptive methods and give you the information you need in order to decide which
contraceptive method is the right choice for you.
The following table shows the percent of women who got pregnant while usin different kinds of
contraceptive methods. It gives both the lowest expected rate of pregnancy (he rate expected
in women who use each method exactly as it should be used and the typical rate of pregnancy
(which includes women who became pregnant because they forgot to use their birth control or
because they did not follow the directions exactly).
Percent of Women Experiencing an Accidental Pregnancy
in the First Year of Continuous Use
+ if you have had cancer of the breast
- if you have had a stroke
- if you have or have had blood clots (phlebitis) in your legs
- if you have problems with your liver or liver disease
- if you are allergic to DEPO-PROVERA (medroxyprogesterone acetate or any of its other
ingredients).
What other things should I consider before using DEPO-PROVERA
Contraceptive Injection?
You will have a physical examination before your doctor prescribes DEPO-PROVERA. It is
important to tell your health-care provider if you have any of the following:
* a family history of breast cancer
- an abnormal mammogram (breast x-ray), fibrocystic breast disease, breast nodules or lumps, or
bleeding from your nipples
" kidney disease
" irregular or scanty menstrual periods
- high blood pressure
- migraine headaches
*astfima
" epilepsy (convulsions or seizures)
" diabetes or a family history of diabetes
- a history of depression
" if you are taking any prescription or over-the-counter medications
This product is intended to prevent pregnancy. It does not protect against
transmission of HIV (AIDS) and other sexually transmitted diseases such as
chlamydia, genital herpes, genital warts, gonorrhea, hepatitis B, and syphilis.
What if I want to become pregnant after using DEPO-PROVERA Contraceptive
injection?
Because DEPO-PROVERA is a longacting birth control method, it takes some time after your last
injection for its effect to wear off. Based on the results from a large study done in the United States,
for women who stop using DEPO-PROVERA in order to become pregnant, it is expected that
about half of those who become pregnant will do so in about 10 months after their last injection;
about two thirds of those who become pregnant will do so in about 12 months; about 83% of
those who become pregnant will do so in about 15 months; and about 93% of those who become
re nant will do so in about l8 months after their last injection. The length of time you use
What a E rAhas no effect on how ongit takes u to become pregnanafte ustop using it.
What are the risks of using DEPO- ROV RA Contraceptive injection?
I.Jrregulor Menstrual Bleecling
The side effect reported most frequently by women who use DEPO-PROVERA for
contraception is a change in their normal menstrual cycle. During the first year of using
DEPO PROVERA, you might have one or more of the following changes: irregular or
unpredictable bleeding or spotting, an increase or decrease in menstrual bleeding, or no bleeding
at all. Unusually heavy or continuous bleeding, however is not a usual effect of DEPO-PROVERA;
and if this happens, you should see your health-care provider right away. With continued use of
DEPO-PROVERA, bleeding usually decreases, and many women stop having periods completely.
In clinical studies of DEPO-PROVERA, 55% of the women studied reported no menstrual
bleeding (amenorrhea) after I year of use, and 68% of the women studied reported no menstrual
bleeding after 2 years of use. The reason that your periods stop is because DEPO-PROVERA
causes a resting state in your ovaries. When your ovaries do not release an egg monthly, the
regular monthly growth of the lining of your uterus does not occur and, therefore, the bleeding
that comes with your normal menstruation does not take place. When you stop using
DEPO-PROVERA your menstrual period will usually in time, return to its normal cycle.
2Bone Mineral Changes
Use of DEPO-PROVERA may be associated with a decrease in the amount of mineral stored in
your bones. This could increase your risk of developing bone fractures. The rate of bone mineral
loss is greatest in the early years of DEPO-PROVERA use, but after that, it begins to resemble the
norm:l rateof oemeelated hone mineralio ms
6.Other Risks
Women who use hormone-based contraceptives may have an increased risk of blood clots or
stroke. Also, if a contraceptive method fails, there is a possibility that the fertilized egg will begin
to develop outside of the uterus (ectopic pregnancy). While these events are rare, you should
tell your health-care provider if you have any of the problems listed in the next section.
What symptoms may signal problems while using DEPO-PROVERA
Contraceptive Injection?
Call your health-care provider immediately if any of these problems occur following an injection
of DEPO-PROVERA:
sharp chest pain, coughing up of blood, or sudden shortness of breath (indicating a possible clot
in the lung)
" sudden severe headache or vomiting, dizziness or fainting, problems with your eyesight or
speech, weakness, or numbness in an arm or leg (indicating a possible stroke)
" severe pain or swelling in the calf (indicating a possible clot in the leg)
" unusually heavy vaginal bleeding
' severe pain or tenderness in the lower abdominal area
pristent pain, pus, or bleeding at the injection site
What are the possible side effects of DEPO-PROVERA Contraceptive Injection?
IWeight Coin
You may experience a weight gain while you are using DEPO.PROVERA. About two thirds of
the women who used DEPO-PROVERA in clinical trials reported a weight gain of about 5 pounds
during the first year of use. You may continue to gain weight after the first year. Women in one
large study who used DEPO-PROVERA for 2 years gained an average total of 8.1 pounds over
those 2 years, or a proximately 4 pounds per year Women who continued for 4 years gained an
average total of 3.8 pounds over those 4 years, or approximately 3.5 pounds per year: Women
who continued for 6 years gained an average total of 16.5 pounds over those 6 years, or
approximately 2.75 pounds per year
?.Dther Side Effects
In a clinical study of over 3,900 women who used DEPO-PROVERA for up to 7 years, some
women reported the following effects that may or may not have been related to their use of
DEPO-PROVERA: Irregular menstrual bleeding, amenorrhea, headache, nervousness, abdominal
cramps, dizziness, weakness or fatigue, decreased sexual desire, leg cramps, nausea, vaginal
discharge or irritation, breast swelling and tenderness, bloating, swelling of the hands or feet,
backache, depression, insomnia, acne, pelvic pain, no hair growth or excessive hair loss, rash, hot
flashes, and joint pain. Other problems were reported by very few of the women in the clinical
trials, but some of these could be serious, These include convulsions, jaundice, urinary tract
infections, allergic reactions, fainting, paralysis, osteoporosis, lack of return to fertilitydeep vein
thrombosis, pulmonary embolus, breast cancet or cervical cancer If these or any other problems
occur during your use of DEPO-PROVERA, discuss them with your health-care provider
Should any precautions be followed during use of DEPO-PROVERA
Contraceptive Injection?
LMissed Periods
During the time you are using DEPO-PROVERA for contraception, you may skip a period, or your
periods may stop completely If you have been receiving your DEPO-PROVERA injections
regularly every 3 months (I3 weeks), then you are probably not pregnant. Howeve, if you think
that you may be pregnant, see your health-care provider
2.Lbortory Test Interacions
If you are scheduled for any laboratory tests, tell your health-care provider that you are using
DEPO-PROVERA for contraception. Certain blood tests are affected by hormones such as
DEPO-PROVERA.
3.Drug Interactions
Cytadren (aminoglutethimide) is an anticancer drug that may significantly decrease the
effectiveness of DEPO-PROVERA if the two drugs are given during the same time.
4,Nursing Mothers
Although DEPO-PROVERA can be passed to the nursing infant in the breast milk, no harmful
effects have been found in these children. DEPO-PROVEPA does not prevent the breasts from
nrnduring milk, n it can h used hv nursing mothers. However to minimize the amount of
cally placing in the top six," Michigan
coach Jon Urbanchek said. "If every-
thing goes according to plan, being in
the top six will be our realistic goal and
expectation. The team looks healthy
and they're ready to go"
Eleven swimmers and one diver will
represent the Wolverines in Austin,
Texas, at the championships.
On the list of Michigan swimmers
and divers to look for are freshman sen-
sation Peter Vanderkaay and junior phe-
nomenon Dan Ketchum.
"Ketchum should be up there in the
top of the 200 freestyle," Urbanchek
said. "Vanderkaay should also be up
there in the 1650 freestyle and the 500
freestyle. Our 800-freestyle relay
should also do well. Furthermore, our
4x100-freestyle relay and the 4x100-
medley relay should capture a victory
or two. So it looks good for us.
The competition will not be easy for
the Wolverines to conquer. According
to the College Swimming Coaches
Association of America, Michigan lies
behind No. 1 Stanford, No. 2 Auburn
and No. 3 California. Stanford is the
only one of the top three that Michigan
has faced this season, and it lost 89.5-
148.5.
"Basically there are two real good
teams," Urbanchek said. "It's Auburn
and Stanford. They're going to duke it
out for first and second place. For third
place, there is about two or three teams
fighting for that spot. Perhaps Texas,
Florida and USC will be fighting for
the third-place spot."
Following the Wolverines in the
rankings is also No. 6 Minnesota,
which came in a close second to Michi-
gan in the Big Ten Championship.
"Minnesota is not going to be ahead
of us," Urbanchek said. "I think they're
going to be very close to us. However,
the ranking on paper is one thing, and
the way they perform under pressure in
+lP matar e .ann+LarT nrafmr n-r nar-
0
S
Lowest
Method Expected Typical
REPO-PROVERA 0.3 0.3
implanits (Norp lans) 0.21 02
Female sterilization 02 04
Male sterilization 0.1 0.15
Oral contracept ve (pill) 3
Comiuned 0
Progestogen only 0.5
uD 3
Pmgestasert 2.0
Copper T 380A 0.8
i
f